摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5,10,15,20-tetraphenylporphyrinato)acetatogadolinium(III) | 1335421-91-4

中文名称
——
中文别名
——
英文名称
(5,10,15,20-tetraphenylporphyrinato)acetatogadolinium(III)
英文别名
——
(5,10,15,20-tetraphenylporphyrinato)acetatogadolinium(III)化学式
CAS
1335421-91-4
化学式
C46H31GdN4O2
mdl
——
分子量
829.028
InChiKey
PRBNOXUVXVFILD-YKKPBKTHSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为产物:
    描述:
    四苯基卟啉 、 gadolinium(III) acetate tetrahydrate 以 further solvent(s) 为溶剂, 以20%的产率得到(5,10,15,20-tetraphenylporphyrinato)acetatogadolinium(III)
    参考文献:
    名称:
    The magnetocaloric effect and the heat capacity of aqueous suspensions of porphyrin complexes of rare earth elements according to microcalorimetric data
    摘要:
    The magnetocaloric effect (MCE) and heat capacity during the magnetization process of (5,10,15,20-tetraphenylporphyrinato)acetatogadolinium(III), (AcO)GdTPP, and (5,10,15,20-tetraphenylporphyrinato)chlorogadolinium(III) complexes, (Cl)GdTPP, in the form of 6%-aqeous suspensions are determined by the microcalorimetric method in a range of temperatures from 278 to 318 K and magnetic fields from 0 to 1 T. It is found that MCE for all the complexes are positive, i.e., at applying a magnetic field in the adiabatic conditions temperature of a suspension of complex increases. It is established that MCE increases with an increase in magnetic induction at all temperatures and decreases with an increase in temperature at all magnetic fields. It is shown that the substitution of chloride ligand by acetate in (X)GdTPP leads to a significant increas in MCE and its temperature dependence; in the case of (Cl)GdTPP actually MCE does not depend on temperature. Relationships between magnetothermal properties and structure of the complexes are analyzed. The conclusion is argumented that the reason of changes in magnetothermal properties after the replacement of axial ligand in gadolinium complexes and complexes of lanthanides with an unsymmetrically filled f-shell is non-planar geometry of the coordination site and specific electronic properties of the central ion. It is concluded that heat capacity of the complexes slightly increases with an increase in temperature and more noticeably in the case of (AcO)GdTPP; a magnetic component of heat capacity is revealed only in (AcO)GdTPP at temperatures above 298 K, which is connected perhaps with a temperature change in the crystal lattice of the complex and influence of the magnetic properties of gadolinium ion on this change.
    DOI:
    10.1134/s0036024412030181
点击查看最新优质反应信息

同类化合物

苯胺,4-肼基-3-甲氧基-N-苯基- 环丁[b][1,2]恶唑并[4,5-e]吡啶 异恶唑并[5,4-B]吡啶-3-胺 异噁唑并[5,4-c]吡啶-3-胺 异噁唑并[5,4-b]吡啶-3-醇 异噁唑并[4,5-b]吡啶-3-胺 异噁唑并[4,5-b]吡啶-3(2H)-酮 [1,2]恶唑并[5,4-e]吲嗪 9-氧杂-3-氮杂三环[5.2.1.03,8]癸-1,5,7-三烯 7H-[1,3]恶唑并[3,2-a]环氧乙烷并[d]吡啶 7-羟基-3-甲基[1,2]恶唑并[4,5-b]吡啶-5(4H)-酮 6-甲氧基-3-甲基[1,2]恶唑并[4,5-c]吡啶 6-(叔丁基)-3-甲基异噁唑并[5,4-B]吡啶-4-羧酸 5-肼基-3-甲基[1,2]恶唑并[4,5-b]吡啶 5-乙基-3-甲基[1,2]恶唑并[5,4-b]吡啶 5-乙基-3-甲基[1,2]恶唑并[4,5-b]吡啶 5,7-二氯-3-甲基异噁唑并[4,5-B]吡啶 4-甲氧基-3-甲基[1,2]恶唑并[5,4-b]吡啶 4-氧杂-7-氮杂三环[4.3.1.03,7]癸-1(9),2,5-三烯 4,6-二甲基异噁唑(5,4-B)吡啶-3-胺 3-甲基异噁唑并[5,4-b]吡啶 3-甲基[1,2]恶唑并[5,4-b]吡啶-5-甲酰氯 3-甲基[1,2]恶唑并[4,5-b]吡啶2-氧化物 3-甲基-6-噻吩-2-基异恶唑并[5,4-b]吡啶-4-羧酸 3-甲基-5H-异恶唑并[4,5-c]吡啶-4-酮 3-溴异噁唑并[5,4-B]吡啶 3-氨基异恶唑[4,5-C]并吡啶 3-(溴甲基)异噁唑并[5,4-B]吡啶 3-(1,3-苯并二恶唑-5-基)-N-[(1S)-1-苯乙基]-异唑并[5,4-c]吡啶-5-胺 3,6-二甲基[1,2]恶唑并[5,4-b]吡啶-4-醇 3,6-二甲基[1,2]恶唑并[5,4-b]吡啶 3,4-二甲基[1,2]恶唑并[5,4-b]吡啶-6(7H)-酮 2H-环戊二烯并[d]异噻唑并[5,4-b]吡啶(9CI) 2H-环戊二烯并[b][1,2]恶唑并[4,5-e]吡啶 2H-[1,2]恶唑并[5,4-b]吡咯并[3,4-D]吡啶 2-氯-N-异噁唑并[5,4-B]吡啶-3-基乙酰胺 1H-咪唑,1-丁基-2,5-二氢-2-(1-甲基乙基)- Methyl 3-cyclohexyloxy-6-cyclopropyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylate Prop-2-ynyl 6-cyclopropyl-3-methyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylate (S)-ethyl 2-(2-((3,5-dimethylisoxazol-4-yl)(hydroxy)methyl)furo[3,2-b]pyridin-5-yl)acetate (6-Chloropyridin-3-yl)methyl 6-cyclopropyl-3-methyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylate 5-Furyl-7-methyl-furo<2,3-c>pyridin 3-methyl-6,7,8,9-tetrahydro-5H-cyclohepta[b]isoxazolo[4,5-e]pyridine 6-bromoisoxazolo[4,5-b]pyridin-3-amine 7-((S)-2-hydroxy-1-methyl-ethylamino)-[1,6]naphthyridine-2-carboxylic acid [(S)-(3-fluoro-phenyl)-(1-methyl-1H-pyrazol-4-yl)-methyl]-amide 7-bromo-3-(4-chloro-phenyl)-4-hydroxy-isoxazolo[5,4-c]pyridine-5-carboxylic acid ethyl ester 3-(4-methoxy-phenyl)-4-hydroxy-isoxazolo[5,4-c]pyridine-5-carboxylic acid ethyl ester 6-Cyclopropyl-3-methoxy-[1,2]oxazolo[5,4-b]pyridine-4-carboxylic acid Methanone, (3-amino-1-piperidinyl)[6-(2,5-dimethyl-3-thienyl)-3-methylisoxazolo[5,4-b]pyridin-4-yl]- 9-(4-Chloro-phenyl)-3-(3,4-dichloro-phenyl)-5-methyl-isoxazolo[4,5-e][1,2,4]triazolo[4,3-c]pyrimidine